Forte Biosciences
FBRX----
Forte Biosciences (FBRX)
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a propr...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Forte Biosciences Analyst Rating
View MoreForecast & Rating
Jul 21, 2026Price forecast
$66.6019.73%
Forecast & RatingStrong buy
6analysts
- Strong buy83.33%
- Buy16.67%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- rttnews · 1 day ago, 03:38 AM
Biotech Stocks At 52-Week Highs - ADVB Surges +73%, BLFS Rises After Acquisition, FBRX, SLN, LBRX
- Market Beat · Jul 21 at 05:14 AM
Forte Biosciences, Inc. (NASDAQ:FBRX) Receives Consensus Rating of "Moderate Buy" from Analysts
- rttnews · Jul 19 at 12:05 PM
5 Undervalued Stocks That Soared: SION +277%, FBRX +306%, NKTR +869% & More
- Simplywall · Jul 19 at 04:03 AM
Is Forte Biosciences (FBRX) Fully Valued Following Its Positive FB102 Vitiligo Data?
- Global Report · Jul 15 at 04:14 AM
US Niche Equities Post Robust Q1 2026 Growth Amid Broadening Market Breadth
- benzinga_article · Jul 10 at 12:05 PM
12 Health Care Stocks Moving In Friday's Intraday Session
